Skip to main content
. 2016 Apr;5(2):133–140. doi: 10.3978/j.issn.2304-3881.2015.06.01

Table 1. Indications for living donor liver transplantation in the USA.

Low MELD + complications of cirrhosis
HCC outside tumor criteria with favorable tumor biology
HCC within tumor criteria in regions with long (>1 year) wait
Low MELD + cirrhosis + significantly decreased quality of life
Low MELD + cholestatic liver disease with recurrent cholangitis

MELD, model for end-stage liver disease; HCC, hepatocellular carcinoma.